Revolutionizing Wound Care: The Future of BST22 Technology in Healthcare

Dive into the groundbreaking advancements of BST22 technology with M2D1 CEO André Tozello. In this episode, we explore how this innovative solution aims to transform the treatment of chronic wounds, such as diabetic ulcers and bedsores, by speeding up healing and reducing reliance on antibiotics. Currently at TRL 3, BST22 is set to move towards pre-clinical trials, promising a safer, more effective approach to wound care. Join us as we uncover the science behind this vital healthcare advancement and its potential to combat persistent infections.